Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
$4.63
-2.3%
$3.88
$2.34
$8.79
$166.97MN/A205,845 shs34,584 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$2.78
-1.9%
$2.20
$0.82
$3.38
$100.59M1.152.29 million shs1.15 million shs
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$1.19
$1.61
$0.53
$4.49
$20.46M4.671.24 million shs57,029 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$4.78
-1.2%
$4.62
$4.01
$9.33
$78.59M1.3204,580 shs27,927 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
-1.25%+33.15%-12.06%-32.77%+473,999,900.00%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
+4.81%+11.42%+5.20%+91.22%+180.20%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-1.65%-0.83%-34.62%-55.93%+25.30%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+0.41%+2.76%+1.68%+2.11%-10.54%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
N/AN/AN/AN/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2.1102 of 5 stars
3.52.00.00.03.60.00.6
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
3.5336 of 5 stars
3.55.00.00.03.93.30.0
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
1.8636 of 5 stars
3.61.00.00.02.00.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
3.00
Buy$16.50256.37% Upside
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
3.00
Buy$9.00224.32% Upside
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
3.00
Buy$5.00320.17% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.25
Buy$11.67143.87% Upside

Current Analyst Ratings Breakdown

Latest NXL, AVR, MBOT, and SRTS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
4/10/2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00 ➝ $9.00
4/4/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
3/24/2025
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$5.00
3/11/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$18.00 ➝ $13.00
(Data available from 5/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
$2.71M61.59N/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/A$0.38 per shareN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$131.07K155.97N/AN/A$0.43 per share2.77
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$39.49M1.99$0.05 per share96.29$2.98 per share1.61
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$10.74M-$0.65N/AN/AN/AN/A-218.30%-158.17%8/13/2025 (Estimated)
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$4.65M-$0.83N/AN/A-3,407.98%-187.59%-167.21%N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.1011.9520.80N/A15.90%12.60%11.38%8/14/2025 (Estimated)

Latest NXL, AVR, MBOT, and SRTS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/21/2025Q1 2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.15-$0.08+$0.07-$0.08N/AN/A
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
5/13/2025Q1 2025
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
N/A-$0.61N/A-$0.61N/AN/A
5/13/2025Q1 2025
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$0.10-$0.15-$0.05-$0.15$0.04 million$0.04 million
3/26/2025Q4 2024
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.18-$0.20-$0.02-$0.20N/AN/A
3/14/2025Q4 2024
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/A-$0.28N/A-$0.28N/A$0.03 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
N/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
N/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/A
3.64
3.64
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/A
16.42
15.89
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
10.52
7.89

Institutional Ownership

CompanyInstitutional Ownership
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
N/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
16.30%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
0.65%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Anteris Technologies Global Corp stock logo
AVR
Anteris Technologies Global
13836.06 millionN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2036.38 million25.64 millionOptionable
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
317.18 million10.11 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.45 million14.85 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Anteris Technologies Global stock logo

Anteris Technologies Global NASDAQ:AVR

$4.63 -0.11 (-2.32%)
As of 11:54 AM Eastern

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Microbot Medical stock logo

Microbot Medical NASDAQ:MBOT

$2.78 -0.06 (-1.94%)
As of 12:18 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Nexalin Technology stock logo

Nexalin Technology NASDAQ:NXL

$1.19 0.00 (0.00%)
As of 12:17 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$4.78 -0.06 (-1.16%)
As of 12:17 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.